medwireNews: The COVID-19 and Cancer Consortium – CCC19 – which aims to collect data on cancer patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has launched.
“Our intent is to rapidly collect and disseminate information about this especially vulnerable population,” according to a statement on the consortium website.
The consortium comprises more than 30 cancer centers and organizations from across the USA, and has a steering committee of seven experts who specialize in a range of tumor types. The steering committee members are:
- Jeremy Warner and Brian Rini, from Vanderbilt University Medical Center in Nashville, Tennessee;
- Gary Lyman, Nicole Kuderer, and Petros Grivas, from Fred Hutchinson Cancer Research Center in Seattle, Washington;
- Mike Thompson, from Aurora Health Care in Milwaukee, Wisconsin; and
- Gilberto Lopes, from Sylvester Comprehensive Cancer Center in Miami, Florida.
Clinicians can submit reports on their cancer patients w ho develop COVID-19 via a survey on the website.
medwireNews is an independent medical news service provided by Springer Healthcare. © 2020 Springer Healthcare part of the Springer Nature group
27 March 2020: The coronavirus pandemic is affecting all healthcare professionals across the globe. Medicine Matters’ focus, in this difficult time, is the dissemination of the latest data to support you in your research and clinical practice, based on the scientific literature. We will update the information we provide on the site, as the data are published. However, please refer to your own professional and governmental guidelines for the latest guidance in your own country.